Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
NPJ Cardiovascular Health|March 3, 2026
Enrollment of all-female and lactating or pregnant female participants in cardiovascular trialsPolyn Luz S Pine, Frederick Berro Rivera, John Vincent U Magalong, et al.
JACC. Advances|November 30, 2025
Valvular Heart Disease Interventional Trials From 2000 to 2024: A Systematic ReviewFrederick Berro Rivera, Chieh-Mei Tsai, Polyn Luz S Pine, et al.
JACC. Advances|November 25, 2024
Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists: A Systematic ReviewFrederick Berro Rivera, Mc John Caro Ybañez, John Vincent Magalong, et al.
Current Medical Research and Opinion|December 12, 2024
Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trialsFrederick Berro Rivera, Marielle Nicole Cabusas Chin, Polyn Luz S Pine, et al.
JACC. Advances|March 16, 2026
Trends and Predictors of Premature Termination of Cardiovascular Trials: A Systematic ReviewFrederick Berro Rivera, Nathan Ross B Bantayan, John Vincent Magalong, et al.
Cardiorenal Medicine|August 12, 2024
Sex Disparity in the In-Hospital Outcomes of Patients with Kidney Disease Admitted for Myocardial Infarction: Insights from a Large National DatabaseFrederick Berro Rivera, Jade Monica Marie Ruyeras, Wailea Faye C Salva, et al.
JAMA Network Open|August 31, 2025
Participation of Women in Cardiovascular Trials From 2017 to 2023: A Systematic ReviewFrederick Berro Rivera, John Vincent Magalong, Nathan Ross B Bantayan, et al.
Cardiorenal Medicine|June 27, 2024
Impact of Chronic Kidney Disease on the Outcomes of Patients Undergoing Left Atrial Appendage Occlusion: Insights from a Large National DatabaseFrederick Berro Rivera, Sung Whoy Cha, Akanimo Antia, et al.
Pageof 1